Related Experiment Video
Updated: Jun 22, 2026

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice
Published on: October 6, 2022
Psychopharmacologic treatment of patients with HIV/AIDS
1New York Presbyterian Hospital, 525 East 68th Street, Box 181, New York, NY 10065, USA. sjferran@med.cornell.edu
Abstract:
Psychiatric disorders are common among patients with HIV/AIDS, and psychopharmacologic treatment is a cornerstone of management. The efficacy of psychopharmacologic treatment for depression in HIV/AIDS is relatively well established. However, literature on the treatment of other disorders is limited, which means that we still must determine how standard treatment guidelines may need to be modified in consideration of several key aspects of HIV illness. These include the broad differential diagnosis for psychiatric symptoms and the potential for interactions between psychotropic medications and antiretroviral medications. This paper reviews the literature on psychopharmacologic treatments of key psychiatric disorders in HIV/AIDS as well as differential diagnosis and drug-drug interactions.
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Retrovirus Life Cycles
Drug Therapy
Antianxiety Medications
Psychosis and Antipsychotic Drugs: Overview
Cryptococcal Meningitis
Antidepressant Drugs: MAOIs and Other Agents

